Dr Reddy's Laboratories Shows Resilience Amid Broader Market Decline

Dr Reddys Laboratories has shown notable activity today, gaining 3.4% on May 13, 2025. The stock has outperformed its sector by 2.28%, marking a positive trend as it has recorded consecutive gains over the past three days, accumulating a total return of 7.8% during this period. The stock reached an intraday high of Rs 1238.55, reflecting a rise of 3.61%.
In terms of moving averages, Dr Reddys Laboratories is currently positioned higher than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. This indicates a mixed performance in the context of longer-term trends.

In the broader market, the Sensex has experienced a decline, falling by 509.12 points to 81,740.48, a decrease of 0.84%. Despite this, Dr Reddys Laboratories has demonstrated resilience, with its one-week performance at 6.55% compared to the Sensex's 1.42%. Over the past month, the stock has also outperformed the index, achieving a return of 11.42% against the Sensex's 8.82%.